Search Results - "Hynes, NE"

Refine Results
  1. 1

    ERBB receptors and cancer: the complexity of targeted inhibitors by Hynes, Nancy E, Lane, Heidi A

    Published in Nature reviews. Cancer (01-05-2005)
    “…ERBB receptor tyrosine kinases have important roles in human cancer. In particular, the expression or activation of epidermal growth factor receptor and ERBB2…”
    Get full text
    Journal Article
  2. 2

    ErbB Receptors: Directing key signaling networks throughout life by HOLBRO, Thomas, HYNES, Nancy E

    “…The epidermal growth factor (EGF)-related peptides bind the ErbB receptors, inducing the formation of different homo- and heterodimers. Receptor dimerization…”
    Get full text
    Journal Article
  3. 3

    The ErbB receptors and their role in cancer progression by Holbro, Thomas, Civenni, Gianluca, Hynes, Nancy E

    Published in Experimental cell research (10-03-2003)
    “…The involvement of the ErbB receptor tyrosine kinases in human cancer, as well as their essential role in a variety of physiological events during normal…”
    Get full text
    Journal Article
  4. 4

    The ErbB2/ErbB3 Heterodimer Functions as an Oncogenic Unit: ErbB2 Requires ErbB3 to Drive Breast Tumor Cell Proliferation by Holbro, Thomas, Beerli, Roger R., Maurer, Francisca, Koziczak, Magdalena, Barbas, Carlos F., Hynes, Nancy E.

    “…ErbB2 is a receptor tyrosine kinase whose activity in normal cells depends on dimerization with another ligand-binding ErbB receptor. In contrast,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Abstract PD01-06: Inhibition of the Ret receptor tyrosine kinase in combination with endocrine therapy impacts on migration and metastatic potential of estrogen receptor positive breast cancer models by Hynes, NE, Gattelli, A, Nalvarte, I, Roloff, T

    Published in Cancer research (Chicago, Ill.) (15-12-2012)
    “…The Ret receptor tyrosine kinase is overexpressed in approximately 30% of human breast cancers, many of which are estrogen receptor-alpha positive (ER+). Using…”
    Get full text
    Journal Article
  7. 7

    Renal Memo1 Differentially Regulates the Expression of Vitamin D-Dependent Distal Renal Tubular Calcium Transporters by Moor, Matthias B, Haenzi, Barbara, Legrand, Finola, Koesters, Robert, Hynes, Nancy E, Bonny, Olivier

    Published in Frontiers in physiology (09-07-2018)
    “…Ablation of the Mediator of ErbB2-driven Cell Motility 1 (Memo1) in mice altered calcium homeostasis and renal calcium transporter abundance by an unknown…”
    Get full text
    Journal Article
  8. 8

    Memo interacts with c-Src to control Estrogen Receptor alpha sub-cellular localization by Frei, Anna, MacDonald, Gwen, Lund, Ingrid, Gustafsson, Jan-Åke, Hynes, Nancy E, Nalvarte, Ivan

    Published in Oncotarget (30-08-2016)
    “…Understanding the complex interaction between growth factor and steroid hormone signaling pathways in breast cancer is key to identifying suitable therapeutic…”
    Get full text
    Journal Article
  9. 9

    The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides by MOTOYAMA, Andrea B, HYNES, Nancy E, LANE, Heidi A

    Published in Cancer research (Chicago, Ill.) (01-06-2002)
    “…The ErbB1 and ErbB2 receptor tyrosine kinases (RTKs) play important roles in the development of numerous types of human cancer and, as such, have been pursued…”
    Get full text
    Journal Article
  10. 10

    Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins by KOZICZAK, Magdalena, HOLBRO, Thomas, HYNES, Nancy E

    Published in Oncogene (29-04-2004)
    “…Overexpression of fibroblast growth factor receptor (FGFR) tyrosine kinases has been found in many human breast cancers and has been associated with poor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells by BADACHE, Ali, HYNES, Nancy E

    Published in Cancer research (Chicago, Ill.) (2001)
    “…Interleukin (IL)-6, a multifunctional regulator of immune response, hematopoiesis, and acute phase reactions, has also been shown to regulate cancer cell…”
    Get full text
    Journal Article
  13. 13

    ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling by Graus-Porta, Diana, Beerli, Roger R., Daly, John M., Hynes, Nancy E.

    Published in The EMBO journal (01-04-1997)
    “…We have analyzed ErbB receptor interplay induced by the epidermal growth factor (EGF)‐related peptides in cell lines naturally expressing the four ErbB…”
    Get full text
    Journal Article
  14. 14

    Memo mediates ErbB2-driven cell motility by Hynes, Nancy E, Marone, Romina, Hess, Daniel, Dankort, David, Muller, William J, Badache, Ali

    Published in Nature cell biology (01-06-2004)
    “…Clinical studies have revealed that cancer patients whose tumours have increased ErbB2 expression tend to have more aggressive, metastatic disease, which is…”
    Get full text
    Journal Article
  15. 15

    Cooperation between Fibroblast Growth Factor Receptor-4 and ErbB2 in Regulation of Cyclin D1 Translation by Koziczak, Magdalena, Hynes, Nancy E.

    Published in The Journal of biological chemistry (26-11-2004)
    “…Alterations in ErbB2 or fibroblast growth factor receptor-4 (FGFR-4) expression and activity occur in a significant fraction of breast cancers. Because…”
    Get full text
    Journal Article
  16. 16

    ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency by Lane, H A, Beuvink, I, Motoyama, A B, Daly, J M, Neve, R M, Hynes, N E

    Published in Molecular and cellular biology (01-05-2000)
    “…Overexpression of the ErbB2 receptor, a major component of the ErbB receptor signaling network, contributes to the development of a number of human cancers…”
    Get full text
    Journal Article
  17. 17

    Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells by Civenni, Gianluca, Holbro, Thomas, Hynes, Nancy E

    Published in EMBO reports (01-02-2003)
    “…Constitutive expression of Wnt1 and Wnt5a in HC11 mammary cells led to elevated TCF transcriptional activity. Intriguingly, Wnt‐expressing cells also displayed…”
    Get full text
    Journal Article
  18. 18

    A new therapeutic antibody masks ErbB2 to its partners by Badache, Ali, Hynes, Nancy E

    Published in Cancer Cell (01-04-2004)
    “…In cancer cells, the ErbB2 receptor tyrosine kinase can be activated in two ways: by overexpression or by ligand-mediated stimulation of another ErbB receptor…”
    Get full text
    Book Review Journal Article
  19. 19

    The ErbB-2/HER2 Oncoprotein of Human Carcinomas May Function Solely as a Shared Coreceptor for Multiple Stroma-Derived Growth Factors by Klapper, Leah N., Glathe, Stefanie, Vaisman, Nora, Hynes, Nancy E., Andrews, Glenn C., Sela, Michael, Yarden, Yosef

    “…The erbB-2/HER2 oncogene is overexpressed in a significant fraction of human carcinomas of the breast, ovary, and lung in a manner that correlates with poor…”
    Get full text
    Journal Article
  20. 20

    ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases by Olayioye, M A, Beuvink, I, Horsch, K, Daly, J M, Hynes, N E

    Published in The Journal of biological chemistry (11-06-1999)
    “…Epidermal growth factor (EGF) binding to its receptor, ErbB1, triggers various signal transduction pathways, one of which leads to the activation of signal…”
    Get full text
    Journal Article